ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection

ClinicalTrials.gov ID: NCT00195351

Public ClinicalTrials.gov record NCT00195351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection

Study identification

NCT ID
NCT00195351
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
467 participants

Conditions and interventions

Interventions

  • ceftriaxone sodium + metronidazole Drug
  • tigecycline Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Jan 31, 2008
Completion
Jan 31, 2008
Last update posted
Feb 24, 2013

2005 – 2008

United States locations

U.S. sites
46
U.S. states
26
U.S. cities
41
Facility City State ZIP Site status
Not listed Mobile Alabama 36617
Not listed Laguna Hills California 92653
Not listed Los Angeles California 90033
Not listed Orange California 92868
Not listed Palm Springs California 92262
Not listed San Diego California 92134
Not listed Torrance California 90509
Not listed Denver Colorado 80204
Not listed Denver Colorado 80262
Not listed Hartford Connecticut 06102
Not listed Newark Delaware 19718
Not listed Washington D.C. District of Columbia 20037
Not listed Miami Florida 33136
Not listed Atlanta Georgia 30342
Not listed Honolulu Hawaii 96813
Not listed Chicago Illinois 60612
Not listed Indianapolis Indiana 46202
Not listed Indianapolis Indiana 46280
Not listed Boston Massachusetts 02118
Not listed Springfield Massachusetts 01199
Not listed West Roxbury Massachusetts 02132
Not listed Detroit Michigan 48201
Not listed Grand Rapids Michigan 49506
Not listed Minneapolis Minnesota 55422
Not listed St Louis Missouri 63110
Not listed St Louis Missouri 63131
Not listed Butte Montana 59701
Not listed Lincoln Nebraska 68510
Not listed Laconia New Hampshire 03246
Not listed Buffalo New York 14215
Not listed Bismarck North Dakota 58501
Not listed Fargo North Dakota 58122
Not listed Cleveland Ohio 44109
Not listed Columbus Ohio 43210
Not listed Columbus Ohio 43215
Not listed Toledo Ohio 43608
Not listed Zanesville Ohio 43701
Not listed Pittsburgh Pennsylvania 15261
Not listed Corsiana Texas 75151
Not listed Fort Worth Texas 76135
Not listed Houston Texas 77026
Not listed Houston Texas 77030
Not listed Salt Lake City Utah 84102
Not listed Charlottesville Virginia 22906
Not listed Madison Wisconsin 53792
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00195351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2013 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00195351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →